In support of this, hypothalamus-specific deletion of LanCL1 aggravated the HFD-induced progress of obesity and the impairment of glucose metabolism, while hypothalamus-specific overexpression of LanCL1 improved these defects even with remarkably decreased expressions of some other common antioxidant enzymes. Here, LANCL1 is linked to obesity disorder.